Literature DB >> 23616354

Environmental fungicides and triazole resistance in Aspergillus.

Paul Bowyer1, David W Denning.   

Abstract

Fungal diseases are problematic in both human health and agriculture. Treatment options are limited and resistance may emerge. The relatively recent recognition of triazole resistance in Aspergillus fumigatus has prompted questioning of the origin of resistance. While multiple mechanisms are described in clinical isolates from triazole-treated patients, some de novo resistance is also recognised, especially attributable to TR34 /L98H. Such strains probably arose in the environment, and, indeed, multiple studies have now demonstrated TR(34) /L98H triazole resistance strains of A. fumigatus from soil. Docking and other in vitro studies are consistent with environmental resistance induction through exposure to certain triazole fungicides, notably difenoconazole, propiconazole, epoxiconazole, bromuconazole and tebuconazole. This article addresses the potential implications of this issue for both human health and food security.
© 2013 Society of Chemical Industry.

Entities:  

Keywords:  Aspergillus fumigatus; fungicide; resistance; triazole

Mesh:

Substances:

Year:  2013        PMID: 23616354     DOI: 10.1002/ps.3567

Source DB:  PubMed          Journal:  Pest Manag Sci        ISSN: 1526-498X            Impact factor:   4.845


  17 in total

Review 1.  [Resistant fungi].

Authors:  M J G T Vehreschild; O A Cornely
Journal:  Internist (Berl)       Date:  2015-11       Impact factor: 0.743

Review 2.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

3.  Induction of Mitochondrial Reactive Oxygen Species Production by Itraconazole, Terbinafine, and Amphotericin B as a Mode of Action against Aspergillus fumigatus.

Authors:  Elena Shekhova; Olaf Kniemeyer; Axel A Brakhage
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

4.  Evolution of cross-resistance to medical triazoles in Aspergillus fumigatus through selection pressure of environmental fungicides.

Authors:  Jianhua Zhang; Joost van den Heuvel; Alfons J M Debets; Paul E Verweij; Willem J G Melchers; Bas J Zwaan; Sijmen E Schoustra
Journal:  Proc Biol Sci       Date:  2017-09-27       Impact factor: 5.349

Review 5.  Resistance to antifungals that target CYP51.

Authors:  Josie E Parker; Andrew G S Warrilow; Claire L Price; Jonathan G L Mullins; Diane E Kelly; Steven L Kelly
Journal:  J Chem Biol       Date:  2014-08-27

6.  Evidence for the agricultural origin of resistance to multiple antimicrobials in Aspergillus fumigatus, a fungal pathogen of humans.

Authors:  S Earl Kang; Leilani G Sumabat; Tina Melie; Brandon Mangum; Michelle Momany; Marin T Brewer
Journal:  G3 (Bethesda)       Date:  2022-02-04       Impact factor: 3.542

7.  Development of cross-resistance by Aspergillus fumigatus to clinical azoles following exposure to prochloraz, an agricultural azole.

Authors:  Isabel Faria-Ramos; Sofia Farinha; João Neves-Maia; Pedro Ribeiro Tavares; Isabel M Miranda; Letícia M Estevinho; Cidália Pina-Vaz; Acácio G Rodrigues
Journal:  BMC Microbiol       Date:  2014-06-11       Impact factor: 3.605

8.  Sensitisation of an Azole-Resistant Aspergillus fumigatus Strain containing the Cyp51A-Related Mutation by Deleting the SrbA Gene.

Authors:  Daisuke Hagiwara; Akira Watanabe; Katsuhiko Kamei
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

9.  Hazard of agricultural triazole fungicide: Does cyproconazole induce voriconazole resistance in Aspergillus fumigatus isolates?

Authors:  Maryam Moazeni; Elahe Ghobahi Katomjani; Iman Haghani; Mojtaba Nabili; Hamid Badali; Mohammad Taghi Hedayati; Tahereh Shokohi
Journal:  Curr Med Mycol       Date:  2020-12

Review 10.  Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review.

Authors:  Aícha Daniela Ribas E Ribas; Pierri Spolti; Emerson Medeiros Del Ponte; Katarzyna Zawada Donato; Henri Schrekker; Alexandre Meneghello Fuentefria
Journal:  Braz J Microbiol       Date:  2016-07-07       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.